stockrowIQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
Follow IQV
Alert me
IQVIA Holdings Inc. (IQV) P/B ratio
As of 5 November 2026, IQVIA Holdings Inc. (IQV) trades at a P/B ratio of 6.4×. Over the past ten years it has ranged from 0.0× (December 2016) to 9.3× (December 2021); the current reading is higher than 75% of that period. That is above the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 5.8× | (0.48%) |
| FY2024 | 5.9× | (15.24%) |
| FY2023 | 6.9× | 4.44% |
| FY2022 | 6.6× | (25.78%) |
| FY2021 | 8.9× | 63.76% |
| FY2020 | 5.5× | 13.39% |
| FY2019 | 4.8× | 41.44% |
| FY2018 | 3.4× | 29.11% |
| FY2017 | 2.6× | 103.58% |
| FY2016 | 1.3× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 6.5× | 28.01% |
| Jun 2026 | 5.1× | 12.60% |
| Mar 2026 | 4.5× | (22.60%) |
| Dec 2025 | 5.8× | 13.68% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| WAT Waters Corporation compare | 2.9× |
| LH Labcorp Holdings Inc. compare | 3.3× |
| DGX Quest Diagnostics Incorporated compare | 3.5× |
| IQV IQVIA Holdings Inc. | 6.4× |
| A Agilent Technologies, Inc. compare | 6.6× |
| ILMN Illumina, Inc. compare | 10.1× |
| NTRA Natera, Inc. compare | 28.2× |
| IDXX IDEXX Laboratories, Inc. compare | 28.2× |
| MTD Mettler-Toledo International, Inc. compare | 2,631× |
| Diagnostics & Research industry median | 3.4× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement